Whitepaper: BioFire® mycoplasma solution: results in one hour, fully automated detection system
Posted: 25 June 2020 | bioMérieux | No comments yet
In this whitepaper, bioMérieux describe the potential application of BioFire® FilmArray technology – a well-recognised technology used in infectious disease diagnostics – for rapid at-line detection of mycoplasmas in the pharmaceutical industry.
Routine testing for microbial contaminants is critically required in biopharmaceutical manufacturing to maintain control over product quality, safety and efficacy. In this whitepaper, we describe the potential application of BioFire® FilmArray technology – a well-recognised technology used in infectious disease diagnostics – for rapid at-line detection of mycoplasmas in the pharmaceutical industry.1
Related content from this organisation
- The impact of supply chain risks and LAL reliance
- Whitepaper: BioFire® mycoplasma solution: results in one hour, fully automated detection system
- Application Notes & Whitepapers 2020
- From commensalism to parasitism: the dangers of underestimating cleanroom bacterial contaminants
- How modern chromatography data systems are improving regulatory compliance in pharmaceutical manufacturing
Issue
Related topics
Cell culture automation, Manufacturing, Rapid Microbiological Methods (RMMs), Technology
